Filing exhibits
- 8-K Current report
- 10.1 Asset Purchase Agreement
- 10.2 Promissory Note
- 10.3 Letter
- 10.4 Guaranty
- 10.5 Transition Services Agreement
- 10.6 Trademark License Agreement
- 10.7 Employment Agreement
- 99.1 CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
- Download Excel data file
- View Excel data file
Table of Contents